APA (7th ed.) Citation

R, P., EM, N., DG, V., JK, S., GH, R., JZ, F., . . . JS, H. (1991). Pharmacology and phase I trial of high-dose oral leucovorin plus 5-fluorouracil in children with refractory cancer: A report from the Children's Cancer Study Group. Cancer research, 51(18), 4871.

Chicago Style (17th ed.) Citation

R, Patel, Newman EM, Villacorte DG, Sato JK, Reaman GH, Finklestein JZ, Krailo MD, Hammond GD, and Holcenberg JS. "Pharmacology and Phase I Trial of High-dose Oral Leucovorin Plus 5-fluorouracil in Children with Refractory Cancer: A Report from the Children's Cancer Study Group." Cancer Research 51, no. 18 (1991): 4871.

MLA (9th ed.) Citation

R, Patel, et al. "Pharmacology and Phase I Trial of High-dose Oral Leucovorin Plus 5-fluorouracil in Children with Refractory Cancer: A Report from the Children's Cancer Study Group." Cancer Research, vol. 51, no. 18, 1991, p. 4871.